Search Results - "Alkhatib, Hosam"
-
1
Neoadjuvant immunotherapy prior to surgery for mucosal head and neck squamous cell carcinoma: Systematic review
Published in Head & neck (01-02-2022)“…Given the recent successes of anti‐PD‐1 immunotherapy, many clinical trials have sought to assess the safety and efficacy of this treatment modality in the…”
Get full text
Journal Article -
2
Allergy History and Immunotherapy Response in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Published in Otolaryngology-head and neck surgery (01-03-2024)“…Objective This study examines the association between patient‐reported allergy history and immune checkpoint inhibition (ICI) response in patients with…”
Get full text
Journal Article -
3
Tumor Histological Grade and Immunotherapy Response in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Published in JAMA otolaryngology-- head & neck surgery (01-06-2022)“…Tumor histological factors that predict immunotherapy response in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) are not…”
Get more information
Journal Article -
4
The association of a scholarly concentrations program with medical students' matched residencies
Published in Medical education online (01-12-2023)“…Many medical school curricula include Scholarly Concentrations (SC) programs. While studies have examined how these programs affect students' future research…”
Get full text
Journal Article -
5
Nutritional Status as a Predictive Biomarker for Immunotherapy Outcomes in Advanced Head and Neck Cancer
Published in Cancers (18-11-2021)“…The association between pretreatment nutritional status and immunotherapy response in patients with advanced head and neck cancer is unclear. We…”
Get full text
Journal Article -
6
Impact of comorbidities on outcomes in patients with advanced head and neck cancer undergoing immunotherapy
Published in Head & neck (01-11-2023)“…Abstract Objectives To explore the impact of pre‐existing comorbidities on immunotherapy response, overall and progression‐free survival, and immune‐related…”
Get full text
Journal Article